| Authors: |
Cousijn J; Neuroscience of Addiction (NofA) Lab, Center for Substance Use and Addiction Research (CESAR), Department of Psychology, Education & Child Studies, Erasmus University Rotterdam, Rotterdam, the Netherlands., Kroon E; Neuroscience of Addiction (NofA) Lab, Center for Substance Use and Addiction Research (CESAR), Department of Psychology, Education & Child Studies, Erasmus University Rotterdam, Rotterdam, the Netherlands., Suo C; QIMR Berghofer, Herston, Queensland, Australia.; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, Mary McKillop Institute, School of Behavioural & Health Sciences, Faculty of Health Science, Australian Catholic University, Melbourne, Victoria, Australia.; Turner Institute for Brain and Mental Health, School of Psychological Sciences & Monash Biomedical Imaging Facility, Monash University, Clayton, Victoria, Australia.; School of Psychology, University of Queensland, St Lucia, Queensland, Australia., Freeman TP; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath, UK., Hindocha C; Clinical Psychopharmacology Unit, Research Department of Clinical, Educational & Health Psychology, University College London, London, UK., Quinones-Valera M; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, Mary McKillop Institute, School of Behavioural & Health Sciences, Faculty of Health Science, Australian Catholic University, Melbourne, Victoria, Australia., Lorenzetti V; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, Mary McKillop Institute, School of Behavioural & Health Sciences, Faculty of Health Science, Australian Catholic University, Melbourne, Victoria, Australia.; Clinical Psychopharmacology Unit, Research Department of Clinical, Educational & Health Psychology, University College London, London, UK. |
